 Ironwood Pharmaceuticals, Inc. NASDAQ:IRWD Q1 2022 Earnings Conference Call May 5, 2022 8:30 AM ET Company Participants Matt Roache - Director, Investor Relations Tom McCourt - Chief Executive Officer Mike Shetzline - Chief Medical Officer Sravan Emany - Chief Financial Officer Conference Call Participants Hannah Monigatti - JPMorgan David Amsellem - Piper Sandler Tim Chiang - Northland Capital Markets Boris Peaker - Cowen and Company Operator Good morning. My name is Joseph and I will be your conference operator today. 